BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3266496)

  • 21. Subsite mapping of human salivary alpha-amylase and the mutant Y151M.
    Kandra L; Gyémánt G; Remenyik J; Ragunath C; Ramasubbu N
    FEBS Lett; 2003 Jun; 544(1-3):194-8. PubMed ID: 12782315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in transglycosylation between human pancreatic and salivary alpha-amylases.
    Omichi K; Ikenaka T
    J Biochem; 1983 Dec; 94(6):1797-802. PubMed ID: 6608517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MS characterization of multiple forms of alpha-amylase in human saliva.
    Hirtz C; Chevalier F; Centeno D; Rofidal V; Egea JC; Rossignol M; Sommerer N; Deville de Périère D
    Proteomics; 2005 Nov; 5(17):4597-607. PubMed ID: 16294315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action pattern of porcine pancreatic alpha-amylase on three different series of beta-maltooligosaccharide glycosides.
    Kandra L; Gyémánt G; Farkas E; Lipták A
    Carbohydr Res; 1997 Mar; 298(3):237-42. PubMed ID: 9090818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of human pancreatic and salivary alpha-amylases with carboxymethylamyloses as substrates.
    Satomura S; Okajima S; Hamanaka T; Shintani A; Miyashita Y; Sakata Y
    Clin Chim Acta; 1984 Mar; 138(1):21-9. PubMed ID: 6609027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pH dependence of the action pattern in porcine pancreatic alpha-amylase-catalyzed reaction for maltooligosaccharide substrates.
    Ishikawa K; Matsui I; Honda K; Kobayashi S; Nakatani H
    Arch Biochem Biophys; 1991 Aug; 289(1):124-9. PubMed ID: 1898059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barley malt-alpha-amylase. Purification, action pattern, and subsite mapping of isozyme 1 and two members of the isozyme 2 subfamily using p-nitrophenylated maltooligosaccharide substrates.
    Ajandouz EH; Abe J; Svensson B; Marchis-Mouren G
    Biochim Biophys Acta; 1992 Sep; 1159(2):193-202. PubMed ID: 1390923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inspection of human salivary alpha-amylase action by its transglycosylation action.
    Omichi K; Ikenaka T
    J Biochem; 1988 Dec; 104(6):881-3. PubMed ID: 3266624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the action of human salivary alpha-amylase on 2-chloro-4-nitrophenyl alpha-maltotrioside in the presence of potassium thiocyanate.
    Suganuma T; Maeda Y; Kitahara K; Nagahama T
    Carbohydr Res; 1997 Sep; 303(2):219-27. PubMed ID: 9352636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Chloro-4-nitrophenyl-beta-D-maltoheptaoside: a new substrate for the determination of alpha-amylase in serum and urine.
    Henkel E; Morich S; Henkel R
    J Clin Chem Clin Biochem; 1984 Jul; 22(7):489-95. PubMed ID: 6332876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental evidence for a 9-binding subsite of Bacillus licheniformis thermostable α-amylase.
    Tran PL; Lee JS; Park KH
    FEBS Lett; 2014 Feb; 588(4):620-4. PubMed ID: 24440349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of seminal plasma alpha-amylase that is not inhibited by monoclonal antibodies against the salivary isoenzyme.
    Huguet J; Cortés JD; Arranz B; Fuentes-Arderiu X
    Clin Chim Acta; 1993 Oct; 220(1):123-4. PubMed ID: 8287557
    [No Abstract]   [Full Text] [Related]  

  • 33. Hydrolysis by human alpha-amylase of p-nitrophenyloligosaccharides containing four to seven glucose units.
    David H
    Clin Chem; 1982 Jul; 28(7):1485-9. PubMed ID: 6177444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemistry of human alpha amylase isoenzymes.
    Zakowski JJ; Bruns DE
    Crit Rev Clin Lab Sci; 1985; 21(4):283-322. PubMed ID: 2578342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of non-reducing-end substituted p-nitrophenyl alpha-maltopentaoside (FG5P) as a substrate for a coupled enzymatic assay for alpha-amylases.
    Omichi K; Ikenaka T
    J Biochem; 1985 Apr; 97(4):977-82. PubMed ID: 3161874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.
    Alves MF; Puzer L; Cotrin SS; Juliano MA; Juliano L; Brömme D; Carmona AK
    Biochem J; 2003 Aug; 373(Pt 3):981-6. PubMed ID: 12733990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated measurement of amylase isoenzymes by a double kinetic assay with "blocked" beta-2-chloro-4-nitrophenyl maltopentaoside as substrate and with wheat germ inhibitor.
    Abe A; Nishimura T; Noma A; Hamano K
    Clin Chem; 1991 Aug; 37(8):1345-9. PubMed ID: 1714360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mathematical treatment of data for calculating activities of alpha-amylase isoenzymes.
    Redondo FL
    Clin Chem; 1987 May; 33(5):689-91. PubMed ID: 2436833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of alpha-amylase using a new blocked substrate (2-chloro-4-nitrophenyl 4(4)-O-beta-D-galactopyranosyl-beta-maltotetraoside).
    Majima K; Teshima S; Hamada Y; Kikuchi T; Kawamura Y; Kitahata S
    Clin Chim Acta; 1995 Jan; 234(1-2):177-9. PubMed ID: 7758218
    [No Abstract]   [Full Text] [Related]  

  • 40. Starch and glucose oligosaccharides protect salivary-type amylase activity at acid pH.
    Rosenblum JL; Irwin CL; Alpers DH
    Am J Physiol; 1988 May; 254(5 Pt 1):G775-80. PubMed ID: 2452576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.